A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Digital Technologies


OKRA raises ambitious target to 6 million predictions in Life Sciences by end of 2020

   by Marina Gonzalo    140
OKRA raises ambitious target to 6 million predictions in Life Sciences by end of 2020

Cambridge, UK, September 29th 2020 - Following on from June's breakthrough news that OKRA hit its target of 2 million validated predictions at >95% accuracy a full 6 months early, the company has set its sights on a record-breaking 6 million predictions completed by year end. This means that pharma companies have benefitted from an unparalleled level of support during the most uncertain time in recent memory, using predictions to guide their staff to take the right next step. This is 1 million more than the revised target set only in June.

Aigenpulse launches data analysis suite to automate flow cytometry

   by Aigenpulse    598
Aigenpulse launches data analysis suite to automate flow cytometry

11th September 2020: Life science and data technology innovator, Aigenpulse, is launching its CytoML Experiment Suite – an automated, end-to-end, machine learning solution specifically aimed at streamlining and automating cytometry analysis at scale and replacing manual gating processes. With it, users will benefit from a single point-of-truth about all cytometry data across any organisation.

Aigenpulse introduces novel data intelligence platform to life science markets

   by Alice Chamberlain    334

Life science and data technology innovator, Aigenpulse, is introducing a new state of-the-art data intelligence platform which is designed to expedite the drug discovery and development process. The Aigenpulse platform harnesses the latest artificial intelligence and machine learning tools to deliver advanced analytics to underpin scientific decision making.

OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

   by Marina Gonzalo    385
OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

Cambridge, UK, 19 June 2020 - OKRA, a leading provider of Artificial Intelligence (AI) driven analytics for Life Sciences, today hit an important milestone, delivering 2 million validated predictions so far in 2020, smashing through its yearly target in just half the expected time. This underscores OKRA’s achievements in empowering the pharmaceutical industry with explainable, real-time AI solutions.